TTM
$13.56
YoY change
+22.6%
5Y CAGR
+14.3%
Peak year (2025)
$13.08
Latest annual
$13.08
EPS (Diluted) history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: $13.08
EPS (Diluted) growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: +22.6%
EPS (Diluted) history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| 2025 | $13.08 | +22.6% | +$2.41 | ||
| 2024 | $10.67 | +6.1% | +$0.61 | ||
| 2023 | $10.06 | +25.3% | +$2.03 | ||
| 2022 | $8.03 | -6.6% | −$0.57 | ||
| 2021 | $8.60 | +28.2% | +$1.89 | ||
| 2020 | $6.71 | +37.2% | +$1.82 | ||
| 2019 | $4.89 | +14.8% | +$0.63 | ||
| 2018 | $4.26 | +44.9% | +$1.32 | ||
| 2017 | $2.94 | +20.5% | +$0.50 | ||
| 2016 | $2.44 | +19.0% | +$0.39 | ||
| 2015 | $2.05 | +14.5% | +$0.26 | ||
| 2014 | $1.79 | +2.9% | +$0.05 | ||
| 2013 | $1.74 | +9.4% | +$0.15 | ||
| 2012 | $1.59 | +14.4% | +$0.20 | ||
| 2011 | $1.39 | +16.8% | +$0.20 | ||
| 2010 | $1.19 | +19.0% | +$0.19 | ||
| 2009 | $1.00 | +6.4% | +$0.06 | ||
| 2008 | $0.94 | +28.8% | +$0.21 | ||
| 2007 | $0.73 | +2.8% | +$0.02 | ||
| 2006 | $0.71 | +24.6% | +$0.14 | ||
| 2005 | $0.57 | +3.6% | +$0.02 | ||
| 2004 | $0.55 | +37.5% | +$0.15 | ||
| 2003 | $0.40 | +21.2% | +$0.07 | ||
| 2002 | $0.33 | +22.2% | +$0.06 | ||
| 2001 | $0.27 | +3.8% | +$0.01 | ||
| 2000 | $0.26 | +23.8% | +$0.05 | ||
| 1999 | $0.21 | -310.0% | +$0.31 | ||
| 1998 | −$0.10 | -28.6% | +$0.04 | ||
| 1997 | −$0.14 | -166.7% | −$0.35 | ||
| 1996 | $0.21 | +40.0% | +$0.06 | ||
| 1995 | $0.15 | +50.0% | +$0.05 | ||
| 1994 | $0.10 | +37.9% | +$0.03 | ||
| 1993 | $0.07 | +61.1% | +$0.03 | ||
| 1992 | $0.04 | +12.5% | +$0.00 | ||
| 1991 | $0.04 | — | — |
- 2025$13.08+22.6%
- 2024$10.67+6.1%
- 2023$10.06+25.3%
- 2022$8.03-6.6%
- 2021$8.60+28.2%
- 2020$6.71+37.2%
- 2019$4.89+14.8%
- 2018$4.26+44.9%
- 2017$2.94+20.5%
- 2016$2.44+19.0%
- 2015$2.05+14.5%
- 2014$1.79+2.9%
- 2013$1.74+9.4%
- 2012$1.59+14.4%
- 2011$1.39+16.8%
- 2010$1.19+19.0%
- 2009$1.00+6.4%
- 2008$0.94+28.8%
- 2007$0.73+2.8%
- 2006$0.71+24.6%
- 2005$0.57+3.6%
- 2004$0.55+37.5%
- 2003$0.40+21.2%
- 2002$0.33+22.2%
- 2001$0.27+3.8%
- 2000$0.26+23.8%
- 1999$0.21-310.0%
- 1998−$0.10-28.6%
- 1997−$0.14-166.7%
- 1996$0.21+40.0%
- 1995$0.15+50.0%
- 1994$0.10+37.9%
- 1993$0.07+61.1%
- 1992$0.04+12.5%
- 1991$0.04—
EPS (Diluted) values are taken from IDEXX Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's current diluted EPS (TTM) is $13.56. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, IDEXX Laboratories (IDXX) diluted EPS totalled $13.08 – grew 22.6% year-over-year.
Across 2020–2025 (5 years), IDEXX Laboratories diluted EPS produced a CAGR of +14.3% – sustaining 3 straight years of year-over-year growth.
The record annual diluted EPS stands at $13.08, reached in 2025; the historical low of −$0.14 was recorded in 1997.
IDEXX Laboratories EPS (Diluted) by Year
IDEXX Laboratories EPS (Diluted) 2025: $13.08
IDEXX Laboratories posted diluted EPS of $13.08 in 2025, grew 22.6% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories EPS (Diluted) 2024: $10.67
In 2024, IDEXX Laboratories reported diluted EPS of $10.67, grew 6.1% from 2023.
IDEXX Laboratories EPS (Diluted) 2023: $10.06
IDEXX Laboratories diluted EPS in 2023 was $10.06, grew 25.3% from 2022.
IDEXX Laboratories EPS (Diluted) 2022: $8.03
2022's diluted EPS for IDEXX Laboratories came in at $8.03, declined 6.6% below 2021.
IDEXX Laboratories EPS (Diluted) 2021: $8.60
IDEXX Laboratories diluted EPS in 2021 was $8.60.
See more financial history for IDEXX Laboratories (IDXX). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation